Severe cutaneous scleromyxedema treated by lenalidomide

Severe cutaneous scleromyxedema treated by lenalidomide

Abstract Scleromyxedema is a rare clinical variant of primary cutaneous mucinosis. It is defined by a generalized papular and sclerodermoid eruption associated with monoclonal gammopathy. No specific definitive treatment is known and those tried have inconsistent results. The first‐line treatment is...

Full description

Bibliographic Details
Main Authors: Théo Brochet, Ali Dadban, Quentin Beauvillain, Clemence Boucher, Fanny Dessirier, Christophe Attencourt, Catherine Lok, Pierre Morel, Aurélie Halle, Guillaume Chaby
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:JEADV Clinical Practice
Subjects:
lenalidomide
monoclonal gammopathy
mucinosis
scleromyxedema
Online Access:https://doi.org/10.1002/jvc2.159

Internet

https://doi.org/10.1002/jvc2.159

Similar Items